NEWS AND EVENTS
KEEP IN TOUCH WITH US
13 Jun
2018

TVB News: HKU and CUHK Invented the World's First MRI-based Neurosurgical Robot that Sponsored by Aptorum

With this innovation, approximately half of the time for neurosurgery can be shortened.

28 Feb
2018

Banker Invests into Life Science, Targeting Emerging Market

(Chinese version only)

<ET Net>

股債回報快,有本港「賓架」5年前卻毅然轉型,開創回報無期的生物科技集團。他直認是受清太宗皇太極影響,相信孫子兵法「不硬撼」為王道,有見美國生物科技市場競爭激烈,選擇開拓香港和英聯邦的新興市場,冀把握本港生物科技優勢,投資大學科研成果商品化,長遠目標旗下項目可獨立上市。

著名銀行家禤永明之子禤駿遠,05年創立佳信投資管理公司,投資股票、債券等資產,但在13年卻搖身一變,投資難以估算回報期的生命科學及生物製藥。他指出,金融海嘯後,業界監管愈見嚴密之下,傳統投資基金回報難復昔日,不少從業員離開行業,令他思考需轉型,紮根於一個行業。

冀助科研成果商品化

選擇生物科技,全因其父親禤永明曾經感染沙士,與沈祖堯醫生等人共患難,他親身見證「本港醫療界用生命救人」,亦結識了不同科目的醫生、教授,因著他對醫療界的認識,遂開創知臨集團,投資生命科學和生物製藥研究,冀推動大學科研成果落地推出市場。

禤駿遠雖然是「賓架」出身,卻對中國歷史及文化深有研究,2010年獲得中大比較與公共歷史文學碩士。他表示,從皇太極身上學會《孫子兵法》:「夫兵形象水,水之形,避高而趨下;兵之形,避實而擊虛」的真諦,做事不會硬撼,因應環境變化而改變策略。

明末時,後金攻打大明,明名將袁崇煥向當時管治澳門的葡萄牙人購入多座大炮,建構起固若金湯的關寧錦防線,清太祖努爾哈赤久攻不下,更有傳他是被袁崇煥的炮火所傷而死,而繼承者皇太極決定不硬撼,繞道直取北京,迫得袁崇煥回救北京,同時引起崇禎疑心袁通敵,將袁凌遲處死。

港不缺製藥人才 惟欠職位

禤稱,有不少人覺得發展生物科技必定去美國,實際美國市場競爭激烈,貿然進入就有如努爾哈赤硬撼袁崇煥的大炮。他決定開拓新興市場,活化有多間全球頂尖醫學院、卻鮮有私人研藥的英聯邦和香港市場,可大大增加成功機會率。

他續稱,香港具有多樣優勢,如大學有出色的醫學科研成果,醫學界又早已建立國際網絡,而且港大和中大各有一個臨床試驗中心,不論美國食品藥品管理局(FDA)和中國國家食品藥品監督管理總局(CFDA)也接受香港的實驗數據,加上背靠內地不缺資金,又指本港不缺人才,只是以往缺類似職位,不少港人曾任美加大藥廠實驗室研究員,現要將人才重新發掘出來,其集團在港建立的實驗室,於2個月內已經建成5人藥劑團隊。

不過,本港大學不懂將科研成果落地商品化,亦沒有渠道尋找投資者,該集團主力助他們「落地」商品化。禤不願透露投資金額,但表示研發新藥發展至第一期人體臨床試驗,通常需投資300至400萬美元(2,340萬至3,120萬港元)不等,集團希望2、3年內可推動5至7個項目,以此推算,總投資不少於1,500萬美元(1.1億港元)。

港交所早前公布主板改革諮詢結果,建議容許沒有盈利及收入的生物科技企業,只要達到市值15億元,至少1隻產品已通過第一期臨床試驗,即可上市。禤透露,集團的長遠目標是推動科研項目完成第一期臨床試驗後獨立上市,自行籌集資金繼續發展。

×
×
×
×
Terms of Use

This Website contains information concerning Aptorum Group Limited (“Aptorum Group”) and its affiliates that may be useful to Aptorum Group’s customers, suppliers, employees, directors and shareholders, as well as members of the general public. However, by using this Website you are accepting all of the terms of this disclaimer notice, including exclusions and limitations of liability. If you do not agree with anything in this notice, you should not use this Website.

Aptorum Group does not claim ownership of the materials and product images on the Website that are provided to us by our third party suppliers.

Where our Website contains links to other sites and resources provided by third parties, these links are provided for your information only. We have no control over the contents of those sites or resources, and accept no responsibility for them or for any loss or damage that may arise from your use of them. These links are provided solely as a convenience to you and not as an endorsement by us of the contents on such third party websites.

While reasonable efforts are made to ensure that the contents of this Website are accurate, this Website and its contents are provided on an “as is,” “as available” basis, without warranties of any kind, including any warranty that the Website will be kept up to date, be true and not misleading, or that the Website will always (or ever) be available for use. Aptorum Group and its affiliates disclaim all warranties, express or implied, with respect to the Website and its contents, including, without limitation, any warranties of accuracy, completeness, timeliness, non-infringement, title, merchantability, or fitness for a particular purpose. Because some jurisdictions do not permit the exclusion of certain warranties, these exclusions may not apply to you.

In no event will Aptorum Group or its affiliates be liable for any incidental, indirect, consequential, or special damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of profits, contracts, goodwill, data, information, income, anticipated savings, or business relationships, whether or not Aptorum Group or its affiliates have been advised of the possibility of such damage, arising out of or in connection with the use of this Website or its contents or any other sites linked to this Website.

If you have any concerns about material which appears on our Website, please contact us. We have the right and the ability to remove immediately from our Website any material that is infringing, defamatory, offensive, abusive, harming, deceptive, threatening or otherwise illegal.